15-Deoxy-Gamma 12,14-Prostaglandin J2 Reduces Liver Impairment In A Model Of Cona-Induced Acute Hepatic Inflammation By Activation Of Ppar Gamma And Reduction In Nf-Kappa B Activity

Kan Chen,Jingjing Li,Junshan Wang,Yujing Xia,Weiqi Dai,Fan Wang,Miao Shen,Ping Cheng,Yan Zhang,Chengfen Wang,Jing Yang,Rong Zhu,Huawei Zhang,Yuanyuan Zheng,Jie Lu,Zhuoyi Fan,Yingqun Zhou,Chuanyong Guo

DOI: https://doi.org/10.1155/2014/215631

2014-01-01

PPAR Research

Abstract:Objective. 15-Deoxy-Delta 12,14-prostaglandin J2 (15d-PGJ2) reduces inflammation and has been identified as an anti-inflammatory prostaglandin in numerous animal models. In this study, we investigated both effects of 15d-PGJ2 and its protection mechanism in concanavalin A- (ConA-) induced autoimmune hepatitis in mice. Materials and Methods. In vivo, Balb/C mice were injected with ConA (25 mg/kg) to induce acute autoimmune hepatitis, and 15d-PGJ2 (10 mu g or 25 mu g) was administered 1 h before the ConA injection. The histological grade, proinflammatory cytokine levels, and NF-kappa B and PPAR gamma activity were determined 6, 12, and 24 h after the ConA injection. In vitro, LO2 cells and RAW264.7 cells were pretreated with 15d-PGJ2 (2 mu M) 1 h before the stimulation with ConA(30 mu g/mL). The NF-kappa B and PPAR gamma activity were determined 30 min after the ConA administration. Results. Pretreatment with 15d-PGJ2 reduced the pathological effects of ConA-induced autoimmune hepatitis and significantly reduced the levels of cytokines after injection. 15d-PGJ2 activated PPAR gamma, blocked the degradation of I kappa B alpha, and inhibited the translocation of NF-kappa B into the nucleus. Conclusion. These results indicate that 15d-PGJ2 protects against ConA-induced autoimmune hepatitis by reducing proinflammatory cytokines. This reduction in inflammation may correlate with the activation of PPAR gamma and the reduction in NF-kappa B activity.